MedPath

Protocol implementation of Shared Decision Making in Dutch breast cancer care; a prospective process evaluatio

Conditions
Breast cancerShared decision makingImplementation Decision aidPatient communicationBorstkankerGezamelijk beslissenKeuzehulpenImplementatiePatient communicatie
Registration Number
NL-OMON27250
Lead Sponsor
Trudy.vanderweijden@maastrichtuniversity.nl
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

Patients with newly diagnosed breast cancer, stage I or II who are eligible for breast conserving therapy or mastectomy

Exclusion Criteria

Not understanding the Dutch language

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
With respect to our hypotheses on frequency of registering indication for a patient decision aid in the Multidisciplinary Board, for handing out and actually logging in, and assuming that that we can include 150 patients in total (5 hospitals, 30 patients per hospital), we expect that:<br /><br>-in 120 patients the indication for the decision aid is registered in the Multidisciplinary tumor board, i.e. in 80%, with a 95% CI of 74-86%. <br /><br>-in 105 patients the personalized decision aid will be handed out, i.e. in 70% with a 95% CI of 63-77%.<br /><br>-90 patients will actually log in to the patient decision aid, i.e. 60% with a 95% CI of 53-67%.<br>
Secondary Outcome Measures
NameTimeMethod
Evaluation experiences professionals of applying the Shared Decision Making and the use of the decision aid
© Copyright 2025. All Rights Reserved by MedPath